Latest filing published 02 Dec 2025 for Zivo Bioscience, Inc., €22k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Laith l. Yaldoo on record concern Zivo Bioscience, Inc. We count 10 filings; the first trade dates from 16 October 2024 and the latest from 27 February 2026.
Every open-market trade on record is a purchase: 9 purchases worth €505k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. 2026 to date brings 3 purchases and no sales.
Half of the purchases are above €22k and half below. 6 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 3 March 2026, reports an open-market purchase of €13k in Zivo Bioscience, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations